Genscript Biotech (GNNSF) Stock Price, News & Analysis

Company Overview

GenScript Biotech Corp. is a biotechnology company that provides research, development and manufacturing services to pharmaceutical, biotechnology and academic customers. Its offerings support work in molecular biology, drug discovery, cell and gene therapy, and other life science applications.

The company’s life science services include gene synthesis, DNA and RNA products, oligonucleotides, peptides, recombinant proteins, antibodies, cell lines and related research reagents. GenScript also provides custom biological research, assay development and preclinical services designed to help customers advance candidates from early research toward clinical development.

GenScript has expanded beyond research services into biologics and cell therapy development and manufacturing. Through its subsidiaries and affiliated businesses, the company has participated in the development of cell therapy products and provides contract development and manufacturing services for biopharmaceutical customers. Founded in 2002, GenScript serves customers internationally through operations and facilities in China, the United States, Europe and other regions.

Key Stats

• Today's Range: C$5.50 to C$5.50
• 50-Day Range: C$2.00 to C$6.35
• 52-Week Range: C$1.30 to C$6.55
• Volume: 153 shs
• Average Volume: 3,656 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: OTCMKTS:GNNSF
• CIK: N/A
• Web: www.genscript.com
• Phone: 862558897288
• Fax: N/A
• Employees: 6,165
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A